Bharat Biotech's Covid-19 vaccine 'Covaxin' enters phase-3 trials

India’s first indigenous Covid-19 vaccine candidate Covaxin has commenced Phase III clinical trials on Monday in what is the largest human trials to be taken up in the country for a vaccine for the dreaded coronavirus.